[Summary of the clinical studies reported in the 57th Scientific Session of the American College of Cardiology (Chicago, USA, 30 March-2 April 2008)].

[1]  L. P. D. Isla,et al.  Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales del American College of Cardiology (Atlanta, Estados Unidos, 14-16 de marzo de 2010) , 2010 .

[2]  F. Alfonso,et al.  Resúmenes de los ensayos clínicos presentados en la 55.a Sesión Científica Anual del American College of Cardiology (Atlanta, Georgia, Estados Unidos, 11-14 de marzo de 2006) , 2009 .

[3]  F. Alfonso,et al.  Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association (New Orleans, Estados Unidos, 8-12 de noviembre de 2008) , 2009 .

[4]  G. Moneta.  Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events , 2009 .

[5]  A. Zwinderman,et al.  Simvastatin with or without ezetimibe in familial hypercholesterolemia. , 2008, The New England journal of medicine.

[6]  R. Erbel,et al.  Effect of Rosuvastatin Therapy on Coronary Artery Stenoses Assessed by Quantitative Coronary Angiography: A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden , 2008, Circulation.

[7]  Li-sheng Liu,et al.  Treatment of hypertension in patients 80 years of age or older. , 2008, The New England journal of medicine.

[8]  Warren Smith,et al.  Home use of automated external defibrillators for sudden cardiac arrest. , 2008, The New England journal of medicine.

[9]  S. Solomon,et al.  Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials: The Cross Trial Safety Analysis , 2008, Circulation.

[10]  M. Keltai,et al.  Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial , 2008, The Lancet.

[11]  F. Prati,et al.  Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial. , 2008, JAMA.

[12]  S. Yusuf,et al.  Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.

[13]  Deepak L. Bhatt,et al.  Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. , 2008, JAMA.

[14]  E. Tuzcu,et al.  Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. , 2008, JAMA.

[15]  Patrick W Serruys,et al.  A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial , 2008, The Lancet.

[16]  F. Alfonso,et al.  Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association 2007 (Orlando, EE.UU., 4-7 de noviembre de 2007) , 2008 .

[17]  B. Uretsky,et al.  Thrombus aspiration during primary percutaneous coronary intervention. , 2008, The New England journal of medicine.

[18]  F. Alfonso,et al.  Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales del American College of Cardiology (Atlanta, Estados Unidos, 14-16 de marzo de 2010) , 2007 .

[19]  F. Alfonso,et al.  Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association (Chicago, Estados Unidos, 12-15 de noviembre de 2006) , 2007 .

[20]  J. Bermejo,et al.  Summary of the Clinical Studies Reported in the Scientific Session of the American College of Cardiology 2006 (Atlanta, Georgia, USA, 11-14 March 2006) , 2006 .

[21]  B. Pitt,et al.  Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .